Examining the safety of PPAR agonists - current trends and future prospects.
about
Regulation of EPCs: The Gateway to Blood Vessel FormationUnlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and ObesityPeripheral gating of pain signals by endogenous lipid mediators.Minireview: Challenges and opportunities in development of PPAR agonistsThiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysisCNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models.Cardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy.Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progressionMechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies.Peroxisome proliferator activated receptor-γ-Rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension.Blocking the peroxisome proliferator-activated receptor (PPAR): an overview.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Palmitate-induced Regulation of PPARγ via PGC1α: a Mechanism for Lipid Accumulation in the Liver in Nonalcoholic Fatty Liver Disease.Peroxisome proliferator activating receptor-γ and the podocyte.Autophagy: controlling cell fate in rheumatic diseases.Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism.PPAR Agonists and Metabolic Syndrome: An Established Role?Functional Regulation of PPARs through Post-Translational Modifications.
P2860
Q21284530-0D493BBA-7AE1-4F70-B5BE-BA0958658846Q26774736-F5DCCAAD-67E3-4279-BA83-C9BBB3FB01FBQ33608432-93FC6BFE-C4D6-46F2-AD99-E58330D5955BQ33631921-1122B908-A9A9-4D9D-8080-013B3671D773Q34065266-17B878B4-BE89-4E5D-B7DA-409BDC2D6F64Q34067485-7E2E4468-7325-4814-820F-7A367FAC63E0Q35140057-5836D987-E188-4BDD-A107-099B32C21F1DQ35576310-8F1FDE8B-05E8-4D7D-AE59-5B0A9EFD6AF1Q36833317-4FB17071-1F92-4878-90E5-9091744D2A7EQ37576061-D3D652F9-9E91-4679-8F5A-2311CF1AA709Q38128537-B26E3EA9-E4B2-4545-A4F2-B425CFBA53FFQ38641190-FEF2C239-D112-49C9-BFA3-01C5D5CDC1AEQ38704475-D706B022-74AC-4639-A3EC-8F36C47A760EQ38815188-17E8C819-EAA2-4E9F-B9F6-277675A77DB2Q38873681-93430709-CCDE-4CC7-B0D6-D88CBB523771Q50890478-BF6E2DD0-97F9-4B0C-AE83-F6264879525FQ54936265-675D164C-C942-4D63-943D-D711221F64EBQ55644874-33B0C4A3-4A97-4F89-972B-96D28FE799BA
P2860
Examining the safety of PPAR agonists - current trends and future prospects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Examining the safety of PPAR agonists - current trends and future prospects.
@en
type
label
Examining the safety of PPAR agonists - current trends and future prospects.
@en
prefLabel
Examining the safety of PPAR agonists - current trends and future prospects.
@en
P2093
P2860
P1476
Examining the safety of PPAR agonists - current trends and future prospects.
@en
P2093
Bogdana Balas
Martin Bopst
Matthew B Wright
Michele Bortolini
P2860
P356
10.1517/14740338.2013.741585
P407
P577
2012-11-08T00:00:00Z